New Delhi, Aug. 12 – The recent aviation safety investigation involving Air India has taken a serious turn following reports that the pilot-in-command of a flight from Phuket to Delhi has tested positive for marijuana in a confirmatory drug test. The incident, which occurred on August 4, involved an Airbus A320neo that experienced a sudden, unexpected altitude loss of approximately 300 feet while cruising over Odisha. This severe mid-air event resulted in injuries to 13 passengers and four crew members, prompting an immediate investigation by the Aircraft Accident Investigation Bureau into the operational conduct of the flight crew.
Initial post-flight screenings conducted by authorities returned a non-negative result for psychoactive substances, necessitating further laboratory analysis to rule out false positives from potential therapeutic medications. The final confirmatory report has now identified the presence of marijuana in the pilot’s system. In response to the growing concerns regarding flight safety and regulatory compliance, the Indian Ministry of Civil Aviation has summoned Air India’s outgoing CEO, Campbell Wilson, to discuss the status of the investigation and the broader implications of this development for the airline’s internal protocols and safety standards.
The Directorate General of Civil Aviation mandates strict testing for psychoactive substances among flight crews to ensure public safety. Under these established regulatory frameworks, confirmed positive tests can lead to disciplinary actions ranging from mandatory rehabilitation programs for first-time offenders to the permanent suspension of a pilot’s license for repeat violations. Air India’s internal management is currently under increased pressure to address these findings, as the airline continues to cooperate with the ongoing inquiry to determine if technical failures or human factors contributed to the flight’s altitude drop.
While the primary focus remains on the Aircraft Accident Investigation Bureau’s probe into the technical and pilot-related aspects of the serious incident, the positive drug test introduces significant regulatory complications. As the investigation progresses, authorities are expected to analyze the timeline of the incident alongside the pilot’s physiological status. The incident serves as a critical reminder of the stringent safety requirements within the global aviation industry, highlighting the necessity for rigorous adherence to health and sobriety protocols to maintain the integrity of passenger transport and minimize risks during commercial flight operations.
